|
Hangzhou Go Top Peptide Biotech Co.,Ltd.
|
Cilengitide is a cyclic peptide containing the RGD sequence. The peptide is based on the in vivo αv β3 integrin ligand, and is obtained through a comprehensive use of cyclization, spatial screening and methylation scanning, and has high affinity and selectivity for αv β3 integrin. Tests have shown that the peptide not only can better inhibit the growth of melanoma and glioma, but also can improve the cure rate of other tumors such as head and neck squamous cell tumors when combined with radiotherapy. It has a good market prospect and potential. In peptide synthesis, Cilengitide is produced through a combination of solid-phase peptide synthesis technology and liquid-phase peptide synthesis technology. |
Send Inquiry
|
|
Hangzhou Go Top Peptide Biotech Co.,Ltd.
|
Cilengitide is a cyclic peptide containing RGD sequence.
The peptide alpha v beta 3 integrin ligand based on the body, through the integrated use of cyclization, spatial filtering and methylation scanning and, to the alpha v beta 3 integrin with high affinity and selectivity.
Test shows that the peptides not only can inhibit the growth of melanoma and gliomas, and cooperate with radiotherapy can improve other tumors, such as the cure rate of the head and neck squamous cell cancer, has good market prospects and potential.
In peptide synthesis, Cilengitide by solid phase peptide synthesis technology combined with liquid phase peptide synthesis technology.
Storage: - 20 ℃ under freeze dry, avoid light preservation remark: used only for research, not for human body |
Send Inquiry
|
|
Hangzhou Go Top Peptide Biotech Co.,Ltd.
|
Brand: Gutuo Appearance: white solid Storage: shading, cool and dry, sealed and stored Purity: ≥99% Main use: pharmaceutical intermediates Executive standard: enterprise standard Specification: 25kg/barrel or 1kg/bag (subject to customer requirements) Sales scope: nationwide |
Send Inquiry
|
Pharma Sources Insight July 2025
